Transplantation Conditioning
"Transplantation Conditioning" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.
Descriptor ID |
D019172
|
MeSH Number(s) |
E02.095.465.425.450.800 E05.478.610.800
|
Concept/Terms |
Transplantation Conditioning- Transplantation Conditioning
- Conditioning, Transplantation
- Conditionings, Transplantation
- Transplantation Conditionings
|
Below are MeSH descriptors whose meaning is more general than "Transplantation Conditioning".
Below are MeSH descriptors whose meaning is more specific than "Transplantation Conditioning".
This graph shows the total number of publications written about "Transplantation Conditioning" by people in this website by year, and whether "Transplantation Conditioning" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 5 | 5 |
1997 | 4 | 6 | 10 |
1998 | 1 | 5 | 6 |
1999 | 10 | 7 | 17 |
2000 | 5 | 1 | 6 |
2001 | 6 | 1 | 7 |
2002 | 5 | 3 | 8 |
2003 | 7 | 6 | 13 |
2004 | 7 | 6 | 13 |
2005 | 9 | 3 | 12 |
2006 | 9 | 4 | 13 |
2007 | 9 | 7 | 16 |
2008 | 10 | 7 | 17 |
2009 | 11 | 16 | 27 |
2010 | 10 | 13 | 23 |
2011 | 16 | 14 | 30 |
2012 | 12 | 13 | 25 |
2013 | 18 | 8 | 26 |
2014 | 24 | 14 | 38 |
2015 | 33 | 10 | 43 |
2016 | 13 | 12 | 25 |
2017 | 15 | 21 | 36 |
2018 | 23 | 11 | 34 |
2019 | 23 | 13 | 36 |
2020 | 10 | 25 | 35 |
2021 | 6 | 22 | 28 |
2022 | 1 | 25 | 26 |
2023 | 0 | 8 | 8 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation Conditioning" by people in Profiles.
-
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. Am J Hematol. 2024 May; 99(5):836-843.
-
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Blood. 2023 12 14; 142(24):2105-2118.
-
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group. Lancet Haematol. 2024 Jan; 11(1):e62-e74.
-
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age. Am J Hematol. 2024 Jan; 99(1):38-47.
-
Posttransplantation late complications increase over time for patients with SCID: A?Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. J Allergy Clin Immunol. 2024 01; 153(1):287-296.
-
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica. 2023 Jul 01; 108(7):1900-1908.
-
Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy. Bone Marrow Transplant. 2023 06; 58(6):635-638.
-
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS. Am J Hematol. 2023 05; 98(5):712-719.
-
NCCN Guidelines? Insights: Hematopoietic Cell Transplantation, Version 3.2022. J Natl Compr Canc Netw. 2023 02; 21(2):108-115.
-
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. Am J Hematol. 2023 02; 98(2):E35-E37.